Marina Biotech, Inc. to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
(firmenpresse) - BOTHELL, WA -- (Marketwire) -- 09/08/11 -- Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, announced today that it will present at the Rodman & Renshaw 13th Annual Healthcare Conference on Monday, September 12, 2011, at 1:35 p.m. Eastern Time (10:35 a.m. Pacific Time) at The Waldorf-Astoria in New York, NY. J. Michael French, Marina Biotech President and Chief Executive Officer, will present a corporate overview and business update.
A live audio webcast will be available on the Event Calendar pages of the Investors section of the Company's website at . Please allow time prior to the presentation to register and download any necessary software. A replay of the presentation will be available on the Investors section of the Marina Biotech website under Event Calendar approximately one hour after the live presentation.
About Marina Biotech, Inc.
Marina Biotech is a biotechnology company, focused on the development and commercialization of RNA interference- (RNAi) and RNA-based therapeutics. The Marina Biotech pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs -- in bladder cancer and malignant ascites. Marina Biotech entered into an exclusive agreement with Debiopharm Group for the development and commercialization of the bladder cancer program. Marina Biotech's goal is to improve human health through the development of RNAi- and RNA-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Additional information about Marina Biotech is available at .
Contact:
Marina Biotech, Inc.:
Peter Garcia
Chief Financial Officer
(425) 908-3603
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.09.2011 - 12:30 Uhr
Sprache: Deutsch
News-ID 63575
Anzahl Zeichen: 0
contact information:
Town:
BOTHELL, WA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 248 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Marina Biotech, Inc. to Present at the Rodman & Renshaw 13th Annual Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Marina Biotech, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
